A Foundation Transformer Model with Self-Supervised Learning for ECG-Based Assessment of Cardiac and Coronary Function
Moody JB, Poitrasson-Rivière A, Renaud JM, Hagio T, Alahdab F, Al-Mallah MH, Vanderver MD, Goonewardena SN, Ficaro EP, Murthy VL. (2025). A foundation transformer model with self-supervised learning for ECG-based […]
Diagnostic performance of ¹⁸F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification
Renaud JM, Moody JB, Vanderver MD, Poitrasson-Rivière A, Buckley CJ, Ficaro EP, Murthy VL. Diagnostic performance of ¹⁸F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification. Journal of Nuclear […]
Self-supervised deep representation learning of a foundation transformer model enabling comprehensive ECG-based assessment of cardiovascular health with limited labeled data
Jonathan Moody, Alexis Poitrasson-Rivière, Jennifer M. Renaud, Michael Vanderver, Edward P. Ficaro, Venkatesh Locharla Murthy. Self-supervised deep representation learning of a foundation transformer model enabling comprehensive ECG-based assessment of cardiovascular health with limited labeled data. […]
Automated deep learning segmentation of cardiac inflammatory FDG PET
Poitrasson-Rivière A, Moody JB, Renaud JM, Buckley CJ, Ficaro EP, Murthy VL. Automated deep learning segmentation of cardiac inflammatory FDG PET. Journal of Nuclear Cardiology. 2024;42:102052. Description:This article, published in […]
How to Differentiate Obstructive from Non‑Obstructive CAD with PET: Developments in High‑Resolution Regional Quantification of MBF and MFR
Renaud JM, Al‑Mallah MH, Soman P, de Kemp RA, Beanlands RSB, Armstrong IS, Prior JO, Madamanchi C, Goonewardena SN, Poitrasson‑Rivière A, Moody JB, Ficaro EP, Murthy VL. How to Differentiate Obstructive […]
PYP quantification of amyloid burden in transthyretin amyloid cardiomyopathy and correlation with echocardiogram
Shinn K, Hamer Y, Poitrasson‑Rivière A, et al. PYP quantification of amyloid burden in transthyretin amyloid cardiomyopathy and correlation with echocardiogram. Journal of the American College of Cardiology. 2024;83(13 Suppl). […]
iMFR assessment: optimized PET blood flow quantification for diagnosis of coronary artery disease
Poitrasson-Rivière, A., Moody, J.B., Renaud, J.M. et al. Integrated myocardial flow reserve (iMFR) assessment: optimized PET blood flow quantification for diagnosis of coronary artery disease. Eur J Nucl Med Mol Imaging 51, 136–146 (2023). […]
iMFR assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion
Moody, J.B., Poitrasson-Rivière, A., Renaud, J.M. et al. Integrated myocardial flow reserve (iMFR) assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion. Eur J Nucl Med […]
Improved diagnostic accuracy for coronary artery disease detection with quantitative 3D 82Rb PET myocardial perfusion imaging
Renaud, J.M., Poitrasson-Rivière, A., Moody, J.B. et al. Improved diagnostic accuracy for coronary artery disease detection with quantitative 3D 82Rb PET myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 51, 147–158 (2023). Description:To ensure […]
Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial
Moody, J.B., Poitrasson-Rivière, A., Hagio, T. et al. Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial. J. Nucl. Cardiol. 28, 2313–2329 (2021). Description:This study validated […]